Passage BIO, Inc.·4

Jun 1, 4:25 PM ET

Goldsmith Bruce A 4

4 · Passage BIO, Inc. · Filed Jun 1, 2022

Insider Transaction Report

Form 4
Period: 2022-05-27
Goldsmith Bruce A
DirectorCEO and President
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-05-27+100,000100,000 total
    Exercise: $1.86Exp: 2032-05-26Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]The stock option vests in full on September 1, 2022, subject to the reporting person's continuous service to the issuer on such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION